Halozyme
HALO
409 hedge funds and large institutions have $4.61B invested in Halozyme in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 146 increasing their positions, 144 reducing their positions, and 35 closing their positions.
291% more call options, than puts
Call options by funds: $18.9M | Put options by funds: $4.84M
37% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 35
14% more capital inflows, than outflows
Capital inflows: $378M | Capital outflows: $330M
6% more funds holding
Funds holding: 387 → 409 (+22)
1.02% more ownership
Funds ownership: 93.35% → 94.37% (+1%)
1% more repeat investments, than reductions
Existing positions increased: 146 | Existing positions reduced: 144
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$62.6M |
| 2 |
Epoch Investment Partners
New York
|
+$31.3M |
| 3 |
BlackRock
New York
|
+$19.3M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$17.7M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$78.3M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$38.6M |
| 3 |
Snyder Capital Management
San Francisco,
California
|
-$23.1M |
| 4 |
Millennium Management
New York
|
-$22.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.3M |
HALO Hedge Fund Activity: Q4 2023 in Review
409 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2023, worth a combined $4.61B — down 2% from $4.71B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new HALO positions and 35 closed out — a net gain of 13 holders — while 146 added to existing stakes and 144 trimmed.
The largest buyer was TD Asset Management, adding an estimated $62.6M. The largest seller was Marshall Wace, cutting an estimated $78.3M.
- 409 institutional investors held Halozyme (HALO) as of Q4 2023, up from 387 in Q3 2023.
- Funds reported $4.61B of Halozyme stock for Q4 2023, down 2% quarter-over-quarter.
- 48 funds opened new Halozyme positions in Q4 2023 and 35 closed out, a net change of +13 holders.
- The largest Halozyme buyer in Q4 2023 was TD Asset Management, an estimated $62.6M added.
- The largest Halozyme seller in Q4 2023 was Marshall Wace, an estimated $78.3M sold.
Based on aggregated 13F filings for Q4 2023.